Disc Medicine Net Debt Growth & History (IRON)
Disc Medicine's net debt was −$60.5M for fiscal 2025.
View full Disc Medicine company overviewDisc Medicine annual net debt history
| Fiscal year | Period ended | Net debt | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | −$60.5M | $102.0M | — |
| 2024 | 2024-12-31 | −$162.4M | $195.8M | — |
| 2023 | 2023-12-31 | −$358.3M | −$165.0M | — |
| 2022 | 2022-12-31 | −$193.3M | −$106.9M | — |
| 2021 | 2021-12-31 | −$86.4M | −$95.9M | — |
| 2020 | 2020-12-31 | $9.5M | — | — |
Disc Medicine quarterly net debt
| Fiscal quarter | Period ended | Net debt | Change | YoY change |
|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | −$37.8M | $58.6M | — |
| Q1 2026 | 2026-03-31 | −$57.9M | $34.2M | — |
| Q4 2025 | 2025-12-31 | −$60.5M | $102.0M | — |
| Q3 2025 | 2025-09-30 | −$109.7M | $81.2M | — |
| Q2 2025 | 2025-06-30 | −$96.4M | $182.4M | — |
| Q1 2025 | 2025-03-31 | −$92.0M | $248.6M | — |
| Q4 2024 | 2024-12-31 | −$162.4M | $195.8M | — |
| Q3 2024 | 2024-09-30 | −$190.8M | $177.7M | — |
| Q2 2024 | 2024-06-30 | −$278.8M | $96.7M | — |
| Q1 2024 | 2024-03-31 | −$340.6M | −$105.4M | — |
| Q4 2023 | 2023-12-31 | −$358.3M | −$165.0M | — |
| Q3 2023 | 2023-09-30 | −$368.6M | — | — |
| Q2 2023 | 2023-06-30 | −$375.5M | — | — |
| Q1 2023 | 2023-03-31 | −$235.2M | — | — |
| Q4 2022 | 2022-12-31 | −$193.3M | −$106.9M | — |
| Q4 2021 | 2021-12-31 | −$86.4M | −$95.9M | — |
| Q3 2021 | 2021-09-30 | −$150.1M | — | — |
| Q4 2020 | 2020-12-31 | $9.5M | — | — |
Disc Medicine net debt trends
Over the last five fiscal years, Disc Medicine's net debt decreased from $9.5M to −$60.5M, a change of −$70.0M. The latest reported quarter, Q2 2026, shows −$37.8M.
What net debt means
Net debt compares a company’s interest-bearing debt with its cash and cash equivalents. Positive net debt means debt exceeds cash, while a negative value indicates the company has more cash than debt on this measure.
How net debt is calculated
TickerStat calculates net debt as total interest-bearing debt minus cash and cash equivalents at the same reporting-period end. Short-term investments are not subtracted because they are not included in the standardized cash series. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Disc Medicine source filings ↗